SERPINC1 and Thromboembolism: Yet, patients in our study cohort suffering from thromboembolic incidences did not significantly differ in terms of their ATIII-activity on POD1 (median ATIII no thromboembolisms = 73%, median ATIII thromboembolisms = 69%, P = 0.238).